快速8区肺超声方案与全12区方案在住院COVID-19患者结局预测中相当
两种方案评分均与复合结局相关,8区与12区评分的ROC-AUC差异无统计学意义(0.767 vs 0.754,P=.647),提示8区方案在非机械通气COVID-19患者预后判断中与12区方案同样准确。
要点
- 8区肺超声方案省略后肺区域,评分仍与住院不良结局独立相关。
- 8区与12区评分对复合结局的判别能力无显著差异,可减少暴露。
- 入院时肺超声评分可用于非机械通气COVID-19患者风险分层。
局限性
- 仅纳入非机械通气COVID-19患者,结论外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Safety precautions limit the clinical assessment of hospitalized Coronavirus disease 2019 (COVID-19) patients. The minimal exposure required to perform lung ultrasound (LUS) paired with its high accuracy, reproducibility, and availability make it an attractive solution for initial assessment of COVID-19 patients. We aim to evaluate whether the association between sonographic findings and clinical outcomes among COVID 19 patients is comparable between the validated 12-zone protocol and a shorter, 8-zone protocol, in which the posterior lung regions are omitted.
METHODS: One hundred and one COVID-19 patients hospitalized in a dedicated COVID-19 ward in a tertiary referral hospital were examined upon admission and scored by 2 LUS protocols. The association between the scores and a composite outcome consisting of death, transfer to the intensive care unit (ICU) or initiation of invasive or noninvasive mechanical ventilation was estimated and compared.
RESULTS: LUS scores in both the 8- and the 12-zone protocols were associated with the composite outcome during hospitalization (hazard ratio [HR] 1.21 [1.03-1.42, P = .022] and HR 1.13 [1.01-1.27, P = .037], respectively). The observed difference in the discriminatory ROC-AUC values for the 8- and 12-zone scores was not significant (0.767 and 0.754 [P = .647], respectively).
CONCLUSION: A short 8-zone LUS protocol is as accurate as the previously validated, 12-zone protocol for prognostication of clinical deterioration in nonventilated COVID-19 patients.
引用
- Levy Adatto N, Preisler Y, Shetrit A, et al. Rapid 8-Zone Lung Ultrasound Protocol is Comparable to a Full 12-Zone Protocol for Outcome Prediction in Hospitalized COVID-19 Patients. J Ultrasound Med. 2021. PMID: 34698389. doi:10.1002/jum.15849
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。